Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

dCas9-VPR-mediated transcriptional activation of functionally equivalent genes for gene therapy
Lisa Maria Riedmayr, Klara Sonnie Hinrichsmeyer, Nina Karguth, et al.
Nature Protocols (2022) Vol. 17, Iss. 3, pp. 781-818
Closed Access | Times Cited: 22

Showing 22 citing articles:

CRISPR/Cas9 Landscape: Current State and Future Perspectives
Marina A. Tyumentseva, Marina A. Tyumentseva, В. Г. Акимкин
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16077-16077
Open Access | Times Cited: 32
mRNA trans-splicing dual AAV vectors for (epi)genome editing and gene therapy
Lisa Maria Riedmayr, Klara Sonnie Hinrichsmeyer, Stefan Bernhard Thalhammer, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 24
CRISPR/Cas-Mediated Gene Activation as a Versatile Tool for Treatment of Inherited Retinal Dystrophies
David Manuel Mittas, Zoran Gavrilov, Emina Ucambarlic, et al.
Advances in experimental medicine and biology (2025), pp. 95-99
Closed Access | Times Cited: 1
CRISPR-assisted transcription activation by phase-separation proteins
Jiaqi Liu, Yuxi Chen, Baoting Nong, et al.
Protein & Cell (2023) Vol. 14, Iss. 12, pp. 874-887
Open Access | Times Cited: 22
Pickering emulsion templated proteinaceous microparticles as glutathione-responsive carriers for endocytosis in tumor cells
Weijie Jiang, Xin Guan, Wei Liu, et al.
Nanoscale Horizons (2024) Vol. 9, Iss. 4, pp. 536-543
Closed Access | Times Cited: 4
Novel epigenetic molecular therapies for imprinting disorders
Sung Eun Wang, Yong‐hui Jiang
Molecular Psychiatry (2023) Vol. 28, Iss. 8, pp. 3182-3193
Open Access | Times Cited: 10
Comparison of dCas9-activator complexes for the activation of PDX1 and NGN3 pancreatic genes using the CRISPR system
Fatma Akçakale Kaba, Ersin Akıncı, Mehmet Fatih Cengiz, et al.
Trakya University Journal of Natural Sciences (2025) Vol. 26, Iss. 1, pp. 49-59
Open Access
Optogenetics and Targeted Gene Therapy for Retinal Diseases: Unravelling the Fundamentals, Applications, and Future Perspectives
Merve Kulbay, Nicolas Tuli, Arjin Akdag, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 14, pp. 4224-4224
Open Access | Times Cited: 3
Logical regulation of endogenous gene expression using programmable, multi-input processing CRISPR guide RNAs
Hansol Kang, Dong-Won Park, Jongmin Kim
Nucleic Acids Research (2024) Vol. 52, Iss. 14, pp. 8595-8608
Open Access | Times Cited: 2
A digital CRISPR-dCas9-based gene remodeling biocomputer programmed by dietary compounds in mammals
Jianli Yin, Hang Wan, Deqiang Kong, et al.
Cell Systems (2024) Vol. 15, Iss. 10, pp. 941-955.e5
Closed Access | Times Cited: 2
rAAV-CRISPRa therapy corrects Rai1 haploinsufficiency and rescues selective disease features in Smith-Magenis syndrome mice
Hao‐Cheng Chang, Yu‐Ju Lee, Sehrish Javed, et al.
Journal of Biological Chemistry (2022) Vol. 299, Iss. 1, pp. 102728-102728
Open Access | Times Cited: 11
Advancements in ocular gene therapy delivery: vectors and subretinal, intravitreal, and suprachoroidal techniques
Kyle D. Kovacs, Thomas A. Ciulla, Szilárd Kiss
Expert Opinion on Biological Therapy (2022) Vol. 22, Iss. 9, pp. 1193-1208
Closed Access | Times Cited: 10
CRISPR-Cas9 Direct Fusions for Improved Genome Editing via Enhanced Homologous Recombination
Tahmina Tabassum, Giovanni Pietrogrande, Michael D. Healy, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14701-14701
Open Access | Times Cited: 5
Multifunctional DNA nanoprobe for tumor-targeted synergistic therapy by integrating chemodynamic therapy with gene silencing
Qiaorong Tang, Qianqian Li, Lu Shi, et al.
Nanoscale Horizons (2023) Vol. 8, Iss. 8, pp. 1106-1112
Closed Access | Times Cited: 4
CRISPRa Analysis of Phosphoinositide Phosphatases Shows That TMEM55A Is a Positive Regulator of Autophagy
Kiyomi Nigorikawa, Yu Fukushima, Chinatsu Shimada, et al.
Biological and Pharmaceutical Bulletin (2024) Vol. 47, Iss. 6, pp. 1148-1153
Open Access | Times Cited: 1
mRNA trans-splicing dual AAV vectors for (epi)genome editing and gene therapy
Lisa Maria Riedmayr, Klara Sonnie Hinrichsmeyer, Stefan Bernhard Thalhammer, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Identification of multi-cancer risk genes
S. Rivera
(2024)
Open Access
Regulation of CAR transgene expression to design semiautonomous CAR-T.
Paweł Głowacki, Cezary Tręda, Piotr Rieske
Deleted Journal (2024) Vol. 32, Iss. 3, pp. 200833-200833
Open Access
Brain Diseases Associated with Unstable Repeats
Katharine E. Shelly, Emily G. Allen, Peng Jin
Oxford University Press eBooks (2024), pp. 228-251
Closed Access
Activating UCHL1 through the CRISPR activation system promotes cartilage differentiation mediated by HIF‐1α/SOX9
Shanwei Shi, Ge Yang, Qiqian Yan, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 17
Open Access
Applications of CRISPR technology
Zhiyan Du
Elsevier eBooks (2024), pp. 23-74
Closed Access
Direct conversion of somatic cells into ‘insulin-producing-cells’ by user-defined multiplex-epigenetic-engineering vector (MEEV-β)
Raza Ali Naqvi, Afsar R. Naqvi, Medha Priyadarshini
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Page 1

Scroll to top